Procurement Summary
Country: USA
Summary: Market Forecast Analyses for West Nile Virus Wnv Vaccine and Antiwnv Monoclonal Antibody for Prophylaxis
Deadline: 02 Sep 2026
Posting Date: 28 Aug 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 148086888
Document Ref. No.: 97469
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Due Date for all quotes has been updated to September 2, 2026 at 10am est.
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format prescribed in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. Quotations are being requested, and a separate written solicitation will not be issued.
The Centers for Disease Control and Prevention (CDC) is issuing Request for Quotation (RFQ) No. 75D301-26-Q-79208 using the procedures of FAR Part 12, Acquisition of Commercial Products and Commercial Services, in conjunction with FAR Part 13, Simplified Acquisition Procedures, for the acquisition of Market Forecast Analyses for West Nile Virus (WNV) Vaccine and Anti-WNV Monoclonal Antibody for Prophylaxis. The acquisition will result in the award of a Time-and-Materials (T&M) purchase order.
Description of Requirement
The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), requires contractor support to conduct two comprehensive market forecast analyses:
Human West Nile virus (WNV) vaccine
Anti-WNV monoclonal antibody (mAb) for seasonal pre-exposure prophylaxis
The contractor shall perform market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and preparation of peer-reviewed publications in accordance with the attached Statement of Work (SOW).
Product or Service Code: AN11 - Health R&D Services, Epidemiology
NAICS Code: 541715- Research and Development in the Physical Engineering, and Life Sciences
Period of Performance: September 30, 2026 - September 29, 2027 (12 months).
Delivery
Services shall be performed in accordance with the attached Statement of Work. Deliverables shall be submitted in accordance with the deliverab...
Notice ID: 97469
Department/Ind. Agency: health and human services, department of
Sub-tier: centers for disease control and prevention
Office: cdc office of acquisition services
Product Service Code: an11 - health r&d services; health care services; basic research
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Inactive Dates: sep 02, 2026
Inactive Policy: manual
Documents
Tender Notice
Documents.zip